Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
British Journal of Cancer Sep 01, 2017
Goto Y, et al. – Experts here gauged the impact of novel miR–145–3p regulatory networks on survival in patients with castration–resistant prostate cancer. They observed that small RNA sequencing for lethal castration-resistant prostate cancer (CRPC) and in silico analyses provided novel therapeutic targets for CRPC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
